Ethyl Acetate Fraction from a . Don Extract Inhibits ɑ-MSH-Induced Melanogenesis Through the CAMP/CREB Pathway
Overview
Chemistry
Molecular Biology
Affiliations
The whitening effect of reducing skin pigmentation is one of the most important goals of cosmetics. The purpose of this study was to determine whether extract and its fractions have potential as natural skin-lightening agents. Initially, we screened various fractions of extract using an in vitro antioxidant assay. Then, the inhibitory effects of extract and its fraction on melanogenesis and the related mechanisms were investigated in B16F1 melanoma cells. The results showed that the ethyl acetate fraction (EF) from extract markedly inhibited melanin synthesis in a dose-dependent manner at non-toxic concentrations. Furthermore, EF downregulated both the protein and mRNA levels of tyrosinase, which is a specific enzyme that catalyzes the conversion of tyrosine into melanin. We also found that EF decreased the microphthalmia-associated transcription factor (MITF) at the protein and mRNA levels. EF increased the phosphorylation of ERK and suppressed the phosphorylation of JNK and p38 in ɑ-MSH-induced B16F1 cells. These results indicate that EF can regulate the MAPK pathway. In addition, EF has an anti-melanogenic effect via the downregulation of intracellular cyclic-AMP (cAMP). Nineteen major compounds of EF were identified using LC-MS/MS. Taken together, these results suggest that EF may be a potential anti-melanogenic agent for use in skin-whitening cosmetics and in topical treatments for hyperpigmentation disorders.
Zheng S, Deng R, Xie S, Huang G, Ou Z, Shen Z Arch Dermatol Res. 2025; 317(1):321.
PMID: 39890718 DOI: 10.1007/s00403-024-03752-0.
Global research trends on melasma: a bibliometric and visualized study from 2014 to 2023.
Wang L, Pang Y, Li W, He Q, Zhang X, Liu E Front Pharmacol. 2024; 15:1421499.
PMID: 39119611 PMC: 11306164. DOI: 10.3389/fphar.2024.1421499.